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Abstract
The mechanisms by which genetic variation affects transcription regulation and phenotypes at the 
nucleotide level are incompletely understood. Here, we use natural genetic variation as an in vivo 
mutagenesis screen to assess the genome-wide effects of sequence variation on lineage-
determining and signal-specific transcription factor binding, epigenomics, and transcriptional 
outcomes in primary macrophages from different mouse strains. We find substantial genetic 
evidence supporting the concept that lineage-determining transcription factors (LDTFs) define 
epigenetic and transcriptomic states by selecting enhancer-like regions in the genome in a 
collaborative fashion and facilitating binding of signal-dependent factors. This hierarchical model 
of transcription factor function suggests that limited sets of genomic data for LDTFs and 
informative histone modifications can be used for prioritization of disease-associated regulatory 
variants.
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Inter-individual genetic variation is a major cause of diversity in phenotypes and disease 
susceptibility. While sequence variants in gene promoters and protein-coding regions 
provide obvious prioritization of disease-causing variants, the majority (88%) of GWAS loci 
are in non-coding DNA, suggesting regulatory functions1. Prioritization of functional 
intergenic variants remains challenging due in part to an incomplete understanding of how 
regulation is achieved at the nucleotide level in different cell types and environmental 
contexts2-11. While recent studies have described important roles for lineage-determining 
transcription factors (LDTFs), also referred to as pioneer factors or master regulators, in 
selecting cell type-specific enhancers12-15, the sequence determinants that guide their 
binding are poorly understood. Previous findings in macrophages and B cells suggest a 
hierarchical model of regulatory function6, where a relatively small set of LDTFs 
collaboratively compete with nucleosomes to bind DNA in a cell type-specific manner (Fig 
1a, i->ii). The binding of these factors is proposed to ‘prime’ DNA by initiating deposition 
of histone modifications that are associated with cis-active regulatory regions (Fig. 1a, ii -> 
iii) and enable concurrent or subsequent binding of signal-dependent transcription factors 
that direct regulated gene expression (Fig. 1a, iii ->iv)6,13,15,16. In principle, this model 
provides a straightforward framework that allows non-coding variants to be classified with 
respect to their ability to directly perturb LDTF binding and their potential to exert indirect 
effects on binding of other LDTFs and signal-dependent transcription factors. To test the 
validity of this model and its ability to explain effects of genetic variation on transcription 
factor binding and function, we exploited the naturally-occurring genetic variation between 
the inbred C57BL/6J and BALB/cJ mouse strains (~4 million SNPs and ~750k InDels17) as 
an ‘in vivo mutagenesis screen.’
Direct effects of genetic variation
First, we quantified genome-wide binding patterns of macrophage LDTFs PU.1 and C/EBPα 
from both mouse strains using ChIP-Seq. These experiments identified a combined 82,154 
PU.1 and 54,874 C/EBPα peaks, with less than 1% of sites exhibiting highly significant 
strain-specific binding (PU.1, n=496; C/EBPα, n=263; 4-fold tag count ratio, FDR < 1e−14, 
>90% located >3 kb from gene promoters) (Fig. 1b, c, Extended Data Fig. 1a). Strain-
specific binding was defined using biological ChIP-Seq replicates, which yielded <0.2% 
empirical false positives (Extended Data Fig. 1b-g). Differential binding of PU.1 and C/
EBPα was significantly correlated with differential expression of the nearest gene as 
measured by RNA-Seq (Fig. 1d). There were no apparent differences in genomic context for 
strain-similar and strain-specific binding at inter- or intragenic sites (>3 kb to promoters) as 
defined by CpG content, distance from nearest gene or repetitive element, or conservation 
score (Extended Data Fig. 2a). Instead, strain-specific binding was highly correlated with 
polymorphism frequency. We observed 5-fold enrichment of polymorphisms at strain-
specific versus strain-similar PU.1-bound and C/EBPα-bound regions (Fig. 1e, Extended 
Data Fig. 2b), with the greatest variant density at the peak centers, (Extended Data Fig. 
2c,d).
To investigate direct effects of sequence variants on transcription factor binding, we 
identified the most enriched position weight matrices (PWM) in genomic regions marked by 
histone H3 lysine 4 di-methylation (H3K4me2) or bound by PU.1 or C/EBPα (Extended 
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Data Fig. 3a, Supplementary Table 1). This analysis consistently identified consensus and 
degenerate motifs for the LDTFs PU.1, C/EBP and AP-1 as the most highly enriched 
PWMs. Notably, the frequency of mutations in these motifs increased with strain-specific 
binding of PU.1 and C/EBPα (Extended Data Fig. 2e,f). Excluding strain-specific loci 
without cis-variation (~11%), 41% of strain-specific PU.1 binding directly associated with 
strain-specific mutations in PU.1 motifs in the other strain. For C/EBPα, 44% of strain-
specific binding associated with strain-specific C/EBPα motifs (Fig. 1f).
Although strain-specific binding of PU.1 and C/EBPα was highly linked to strain-specific 
motif mutations, strain-specific motif mutations were also associated with strain-similar 
binding (Extended Data Fig. 3c,d). This raised the question as to whether specific features 
of motif mutations could be used to predict strain-specific binding. Comparison of motif 
mutations in strain-specific to strain-similar peaks revealed three distinct attributes 
contributing to predictive power. First, mutated motifs within 20 bp of the experimentally 
defined binding centers were more highly associated with an effect on binding (PU.1, p = 
1.6e-4; C/EBPα, p = 0.036; Extended Data Fig. 4a-d). Second, the presence of alternate 
motifs within 100 bp of the PU.1 peak centers significantly buffered the effect of strain-
specific PU.1 motifs (Extended Data Fig. 4e,f). Third, after removing peaks with 
alternative motifs, analysis of the nucleotides mutated enabled delineation of an empirically 
defined functional motif that revealed a strong relationship between ‘core’ mutations and 
altered binding (Fig. 1g, Extended Data Fig. 4g-i, p=3.2e-8 PU.1 and p=5.1e-4 C/EBP). 
Taken together, core motif mutations <20 bp from the peak center that lacked alternative 
motifs were 3.5× and 3× more likely to occur in differential versus similar bound peaks for 
PU.1 and C/EBPα, respectively (Extended Data Fig. 4j,k). Notably, up to 90% of these 
mutations were located in differentially bound peaks (Extended Data Fig. 4l,m). To 
investigate the possibility that an algorithm incorporating these characteristics could be used 
to predict the impact of a specific motif mutation on transcription factor binding, we 
performed ChIP-Seq analysis for PU.1 in macrophages derived from a third inbred strain of 
mice, NOD/ShiLtJ (NOD). Of the ~1.4 million identifiable PU.1 motifs in the C57BL/6J 
reference genome, 18,322 contain SNPs that mutate the PU.1 motif in the NOD genome. 
1.6% of these mutations were associated with strain specific binding (Fig. 1h). Of the 244 
NOD PU.1 motif mutations located in PU.1-bound regions in C57BL/6J or BALBc, 68% 
were associated with strain-specific binding. When considering all three variables (motif 
distance, alternative motif, and motif core, Extended Data Fig. 5), 88% of the predicted 
functional mutations were consistent with impaired PU.1 binding in NOD (Fig. 1h).
Variation and collaborative LDTF binding
To investigate the potential impact of mutations in LDTF recognition motifs on 
collaborative binding, we analyzed all strain-specific PU.1 or C/EBPα binding events in 
regions containing LDTF motif mutations. PU.1 motif mutations resulting in loss of PU.1 
binding were frequently associated with a corresponding loss of nearby C/EBPα binding in 
the absence of C/EBP motif mutations (Fig. 2a, top). Conversely, C/EBP motif mutations 
resulting in loss of C/EBPα binding were frequently associated with a corresponding loss of 
nearby PU.1 binding in the absence of PU.1 motif mutations (Fig. 2a, middle). Similar 
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results were observed at locations containing strain-specific mutations in AP-1 binding 
motifs, but intact PU.1 and C/EBP motifs (Fig. 2a, bottom).
We next considered the global relationships of mutations in PU.1, C/EBP, and AP-1 motifs 
with strain-specific binding of PU.1 and C/EBPα, taking into account both consensus and 
‘weak’ motifs for PU.1 and C/EBP. NF-κB motifs were included as controls that were not 
expected to affect PU.1 or C/EBPα binding in unstimulated macrophages (Extended Data 
Fig. 3a,b, Supplementary Table 1). While mutations in PU.1 motifs had the strongest 
effect on strain-specific PU.1 binding, mutations exclusively in C/EBP and/or AP-1 motifs 
also significantly correlated with differential PU.1 binding relative to similarly bound loci 
(Fig. 2b). Similar relationships were observed for C/EBP (Extended Data Fig. 6a). The 
motif distance distributions for co-bound factors were broad (half width ~100 nt), and only a 
minor subset of sites exhibited defined distances expected for direct protein-protein 
interactions (Extended Data Fig. 6b), suggesting transcription factor-nucleosome 
competition as the driving force behind the collaborative binding behavior6,18. Together, 
strain-specific mutations in nearby C/EBP and AP-1 motifs were associated with ~15% of 
strain-specific PU.1 binding at sites with strain-similar PU.1 motifs. Mutations in nearby 
PU.1 and AP-1 motifs were associated with ~30% of strain-specific C/EBPα binding at sites 
with strain-similar C/EBP motifs (Fig. 1f). Overall, 48% of strain-specific PU.1 binding and 
57% of C/EBPα binding was associated with at least one assignable LDTF motif mutation 
(Fig. 1f). To genetically test whether these correlations are consistent with a collaborative 
binding model, we considered all LDTF motif mutations and evaluated their effects on PU.1 
binding in macrophages derived from NOD mice. For polymorphic strain-specific PU.1 loci 
containing strain-specific LDTF motifs (n = 220), PU.1 binding profiles matched the strain 
with shared alleles for 91% and 92% of cases (Fig. 3a). At 8% (n = 17) of the loci, the NOD 
genome broke the C57BL/6J/BALB/cJ haplotypes, and in all cases, the NOD genotype at 
the LDTF motif variant matched the strain with similar binding (Supplementary Table 2), 
indicating that these variants are likely the cause of binding differences. An example is 
shown in Fig. 3b, where PU.1 binds in C57BL/6J but not in BALB/cJ or NOD. Only one 
SNP in this region is associated with PU.1 binding exclusively in C57BL/6J; here, the T 
allele forms part of a neighboring AP-1 motif in C57BL/6J that is mutated by the C allele in 
BALB/cJ and NOD. These findings provide genetic evidence that PU.1 binding to this 
location is dependent on collaborative interactions with AP-1.
To confirm that the allele-specific binding also occurs in heterozygous cells, we performed 
ChIP-Seq for PU.1 and C/EBPα in macrophages from CB6F1/J hybrid mice, which are F1 
offspring of a C57/BL/6J × BALB/cJ cross. In the great majority of cases, alleles bound 
specifically in a parental strain were also bound preferentially in the F1 generation. (Fig. 3c 
and Extended Data Fig. 6c).
Given the genetic evidence that LDTFs collaborate to bind DNA, we next tested the extent 
to which strain-specific LDTF binding explained promoter-distal (>3 kb) strain-specific 
histone modification events, such as H3K4me2 and H3K27Ac deposition, which 
respectively mark ‘primed’ and ‘active’ chromatin19,20 (Fig. 1a, ii->iii). Genomic regions 
exhibiting strain-specific binding of PU.1 and C/EBPα were associated with strain-specific 
H3K4me2 and H3K27ac (Fig. 2a, right columns). Strain-specific histone modifications 
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correlated with nearby gene expression (Fig. 2c), and H3K27Ac modification tracked with 
the corresponding parental allele in CB6F1/J hybrid mice (Fig. 3d). Strain-specific binding 
of PU.1 and C/EBPα were individually correlated with H3Kme2 and H3K27Ac deposition, 
with the combined binding of both factors exhibiting even greater correlation than the 
individual factors (Extended Data Fig. 7a-f). Further, LDTF motif mutations segregated 
with differential LDTF binding and histone modifications (Fig. 2d, Extended Data Fig. 
7g). Together, these findings support the concept that LDTFs play quantitatively important 
roles in establishing these histone modifications, likely through initiating transcription in a 
combinatorial fashion21.
Expression quantitative trait loci (eQTLs) are polymorphic loci whose alleles are associated 
with individual RNA expression levels across a population22. Thus, eQTLs define active 
gene regulatory loci and provide an alternative method for assigning regulatory function to 
gene expression. To interrogate the relationship between histone modification and eQTLs, 
we analyzed previously reported eQTL data from 85 inbred mouse strains in the Hybrid 
Mouse Diversity Panel (HMDP) in primary macrophages23 (see Methods). We found that 
eQTLs overlapped H3K4me2- or H3K27Ac-marked regions at frequencies greater than 
expected by chance, supporting the role of histone modifications as landmarks of regulatory 
activity (hypergeometric test p-values: H3K4me2 = 1e-2147, H3K27Ac = 1e-2290). Next, 
given the highly cell type-specific nature of gene regulation24, we hypothesized that eQTLs 
from different cell types would be reflected in the histone modification profiles in the same 
cell type. We examined liver and macrophage eQTLs for a set of ~130k SNPs from the 
HMDP25 for overlap with H3K27Ac loci defined in macrophages or in liver, pro-B, or 
mouse ES cells20. Macrophage eQTL were more significantly enriched for overlap with 
macrophage H3K27Ac regions than liver H3K27Ac. Similarly, liver eQTL were most 
significantly enriched with liver H3K27Ac relative to macrophage H3K27Ac (Fig. 2e). 
Clustering of H3K27Ac profiles revealed that liver and ES H3K27Ac profiles are most 
similar (Extended Data Fig. 7h), providing an explanation as to why liver eQTLs were 
highly enriched in mES H3K27Ac regions.
LDTF motif mutations affect NF-κB binding
To evaluate the prediction that primed regulatory loci (containing H3K4me2) often require 
additional binding of signal-dependent TFs to achieve regulatory activity (Fig 1a, iii->v), we 
treated C57BL/6J and BALB/cJ macrophages with Kdo2-Lipid A (KLA), a potent and 
specific agonist of TLR426. KLA treatment causes NF-κB to enter the nucleus, bind DNA 
and regulate several hundred target genes26,27. We performed ChIP-Seq for PU.1, C/EBPα 
and the RelA/p65 component of NF-κB in untreated and KLA-treated macrophages and 
observed that 61% of sites that gained p65 were pre-bound by PU.1 and/or C/EBPα without 
KLA. De novo motif analysis indicated that an AP-1 motif was present in 42% of the 
remaining sites, suggesting that AP-1 is responsible for priming a large proportion of the 
p65 cistrome (Extended Data Fig. 8a), in line with previous reports16.
To further interrogate the dependence of p65 on LDTFs we focused on sites that gained p65 
only in one strain (n = 932, >90% promoter-distal, Extended Data Fig. 1a, Fig. 4a, 4th 
column). In the vast majority of cases, PU.1 and/or C/EBPα were bound prior to KLA 
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treatment only in the strain exhibiting p65 binding (Fig. 4a). In addition, strain-specific p65 
binding primarily occurred at loci already marked by H3K4me2, and led to an increase of 
H3K27Ac, consistent with the proposed model. To analyze the effects of genetic variation 
on transcription factor motifs, we performed strain-specific LDTF and NF-κB motif finding 
in polymorphic strain-specific p65-bound peaks (n = 750) (Extended Data Fig. 3b). 
Notably, p65 binding was influenced by mutations in individual LDTF motifs to a similar 
extent as mutations in the NF-κB motif itself (Fig. 4b, Extended Data Fig. 8b). For strain-
specific p65 binding events, 34% could be attributed to assignable mutations in PU.1, C/
EBP, or AP-1 motifs, whereas 9% could be explained by mutations in the assignable NF-κB 
motifs themselves (Fig. 4c). RelA/p65 is known to bind to degenerate and non-canonical 
motifs28 that might not be captured by de novo motif analysis. To gain motif-independent 
insight into variant location and strain-specific TF binding, we assessed the variant 
frequency relative to the centers of strain-specific p65 peaks. Similar to strain-specific PU.1 
and C/EBPα peaks, strain-specific p65 peaks are in regions of higher variant density than 
strain-similar peaks (Extended Data Fig. 8c). In contrast to LDTFs, where strain-
specifically bound regions have a high variant density at their peak centers, the distribution 
of variants at strain-specific p65 peaks is significantly different from those of the LDTFs 
(Kolmogorov-Smirnov p-value < 0.013) as it contains fewer variants at the peak centers and 
is broader (Fig. 4d, Extended Data Fig. 8d-f). This is consistent with p65 binding being 
more affected by sequence variation in motifs of neighboring factors than LDTFs.
Overall, strain-specific p65-bound regulatory sites were significantly correlated with nearby 
genic transcription and mRNA production (Fig. 4e). We tested strain-specifically bound and 
epigenetically marked putative enhancer sequences with strain-specific mutations for 
differential enhancer function in transient and stable reporter assays (Fig. 5a, Extended 
Data Figs. 9a, b). We observed the predicted strain-specific enhancer activity for 18 of 20 
of these genomic sequences. Conversely, enhancer elements with sequence variation in non-
core nucleotides that were not predicted to alter PU.1 or C/EBP binding and that exhibited 
strain-similar binding patterns exhibited similar enhancer activity (Extended Data Fig. 
10a).
Lastly, we tested whether the predicted motif-disrupting variants could specifically explain 
strain-specific enhancer activity by swapping variants at the putative causative alleles in 
C57BL/6J to BALB/cJ while maintaining the genetic background for the remainder of the 
enhancer sequences. Representative examples in which reversal of such SNPs in PU.1, 
C/EBP and p65 motifs reversed strain-specific enhancer activity are illustrated in Fig. 5c 
and Extended Data Figs. 10b,c. In contrast, reversal of nearby SNPs not predicted to alter 
LDTF motifs had no effect on strain-specific enhancer activity (Extended Data Fig. 10c).
Discussion
In concert, we have exploited natural genetic variation to test a collaborative model for 
enhancer selection and function, and conversely explored the ability of this model to explain 
strain-specific differences in transcription factor binding and epigenetic features associated 
with functional enhancers in macrophages. These studies provide genetic evidence that 
lineage-determining transcription factors are dependent on collaborative binding to variably 
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spaced DNA recognition motifs in order to select enhancers and enable binding of signal-
dependent transcription factors. Notably, the variable motif distances observed at co-bound 
LDTF loci suggests that collaborative binding does not generally require direct protein-
protein interactions between the involved transcription factors. The proposed hierarchical 
LDTF collaborative model provides a conceptual framework for prioritization of non-coding 
disease-associated regulatory variants. While all cells express hundreds of transcription 
factors, a large fraction of functional enhancers (~70% in macrophages) are characterized by 
collaborative interactions involving relatively small sets of lineage determining transcription 
factors (e.g., PU.1, AP-1 and C/EBPs). The requirement for collaborative binding 
interactions provides an explanation for why transcription factor binding is lost at sites 
where mutations do not occur in the cognate recognition motif. In the case of NF-κB, for 
example, mutations in the motifs for lineage determining factors were approximately three 
times more likely to result in decreased binding of NF-κB than mutations in the NF-κB 
binding site itself. An essential step in leveraging the collaborative model to pinpoint 
potential disease-causing variants is the definition of relevant LDTF binding sites and 
functionally important variants. At the current level of genome annotation, this cannot be 
achieved by analysis of DNA sequence alone. For example, there are ~1-2×106 identifiable 
PU.1 binding sites in the human29 and mouse genomes, but <10% are actually occupied by 
PU.1 in macrophages. By experimentally defining strain-similar and strain-specific binding 
patterns for PU.1, the relevant sites at which mutations can result in altered function are 
identified. Comparison of PU.1 motif mutations associated with strain-specific versus strain-
similar binding allowed the genetic definition of a functional binding matrix and additional 
distinguishing features that enabled accurate prediction of functional mutations in a third 
strain. Thus, by collecting a relatively limited set of genomic binding data for LDTFs and 
informative histone modifications, this analytical approach can be exploited to explain a 
greater extent of variation in enhancer selection and function than previously possible7,10. 
To further increase the specificity and sensitivity for detecting functional variations, 
identification of transcription factor motifs that permit binding but diverge from the 
consensus PWM, i.e. “weak” motifs, needs to be improved, as such sites are more likely to 
be affected by mutation29,30. In addition, transcription factors less abundant than LDTFs 
likely play individually small but collectively significant roles. At a larger scale, non-cis-
acting, long-range epigenetic mechanisms may also be important for enhancer selection. A 
major goal for the future will be to extend these approaches to understanding natural genetic 
variation associated with human disease.
Methods
Animals and Cell Culture
Thioglycolate-elicited peritoneal macrophages were collected 4 days post-injection from 
male 6-8 wk C57BL/6J, BALB/cJ or CB6F1/J Hybrid mice and plated at 20 × 106 cells/15-
cm petri dish in RPMI1640 + 10% FBS + 1X PenStrep. One day after plating, cells were 
treated with fresh media with or without 100 ng/ml Kdo2-LipidA (KLA) for 1 hour and then 
directly used for downstream analyses. All animal experiments were performed in 
compliance with the ethical standards set forth by UC San Diego's Institutional Annual Care 
and Use Committee (IUCAC).
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ChIP-Seq and Feature Identification
Media was decanted and cells were fixed at room temperature with either 1% 
formaldehyde/PBS for 10 minutes (for PU.1, C/EBPa, H3K27Ac ChIPs) or 2 mM 
disuccinimidylglutarate (DSG, Pierce)/10% DMSO/PBS for 30 minutes followed by 1% 
formaldehyde/PBS for another 15 minutes (p65). After quenching the reaction by adding 
glycine to 0.125 M, cells were washed twice with PBS and snap-frozen in dry-ice/methanol. 
ChIPs for PU.1 (Santa Cruz, sc-352), C/EBPa (Santa Cruz, sc-61) were performed exactly as 
described previously6. The H3K27Ac (Abcam, ab4729) ChIP was performed in the presence 
of 1 mM butyric acid. For p65 (Santa Cruz, sc-372), IP conditions were identical to the ones 
described before6, except that pre-clearing was omitted, and the ChIP was performed with 5 
μg antibody (Santa Cruz, sc-372) pre-bound to 50 μl Protein A Dynabeads (Invitrogen) for 
30 minutes in 0.5% BSA/TE, and a final wash with TE/50 mM NaCl was performed before 
elution. ChIP-Seq library preps for the initial p65 ChIPs were performed as described 
before6, libraries for the replicates were prepared using magnetic beads similar to previously 
described procedures12. ChIPs for H3K4me2 were carried out on MNase-digested chromatin 
as described previously31. To control for open chromatin and library biases, input chromatin 
libraries after sonication were sequenced for each strain, crosslinking condition and ChIP 
lysis protocol. Sequencing libraries were prepared as previously described6 using barcoded 
adapters (NextFlex, Bioo Scientific), and sequenced for 50 cycles on a Hi-Seq 2000 
(Illumina) using CASAVA1.7 or 1.8.
C57BL/6J and BALB/cJ demultiplexed fastq files were mapped to both the mm9 reference 
(C57BL/6J) genome and the BALB/cJ contigs17 using Bowtie0.12.733 with the options –m 1 
--best –n 3 -e 200. Mapping parameters for C57BL/6J and BALB/cJ data allowed 3 
mismatches in the 28 bp seed sequence with up to 5 high quality mismatches in the entire 50 
bp read. NOD ChIP-Seq data were mapped to the mm9 genome using the above options. To 
identify allele-specific reads from CB6F1/J data, ChIP-seq reads were aligned to the 
C57BL/6J or BALB/cJ sequence using Bowtie2-2.0.0-beta734 allowing 0 mismatches in 32 
bp reads with options -N 0 -L 32 --score-min L,0,0 --gbar 17. Tags mapping to both 
genomes were discarded. Resulting allele-specific reads were counted for regions of interest.
For C57BL/6J and BALB/cJ data, reads mapping to only one genome were discarded (<2% 
of total) to avoid bias caused by mappability differences, and reads mapping to both were 
assigned to the mm9 genomic location. Genomic binding peaks for transcription factors PU.
1, C/EBPa, and p65, were identified using the findPeaks command in the HOMER (http://
biowhat.ucsd.edu/homer/) software suite6 with default settings of –style factor: 200 bp peaks 
with 4-fold tag enrichment and 0.001 FDR significance over background (ChIP input), 4-
fold enrichment over local tags, and normalization to 10 million mapped tags per 
experiment. H3K4me2 and H3K27Ac regions used for initial de novo motif finding 
(Extended Data Fig. 3a) were identified using the default parameters of findPeaks –style 
histone with the addition of –nfr centering for H3K4me2 MNase data. For H3K4me2 and 
H3K27Ac peaks identified for comparison to LDTF binding and mutation events (e.g., Fig. 
2d), findPeaks –style peaks was used to define more focal, non-gene associated loci. In 
particular, H3K27Ac regions were identified with the findPeaks options –style factor using –
size 1000bp –L2 (2-fold enrichment over local tags). H3K27Ac peaks were merged between 
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strains using mergePeaks –size given and peaks were resized to 1 kb. Peaks within 3 kb of 
gene promoters were excluded from further analysis. H3K4me2 peaks were identified using 
findPeaks options –style factor –size 500 –L2 –C0 (which allows for unlimited tags 
considered per genome position as may occur with MNase data). Peaks were then centered 
on the best nucleosome-free region (nfr) within a 1 kb window using getPeakTags –nfr. 
Peak files between strains were merged with mergePeaks –size given and H3K4me2 tags 
were counted in 1 kb regions centered on the merged peak file definitions. Peaks were then 
re-centered based on the best nfr in 1 kb identified by getPeakTags –nfr according to the 
strain with more H3K4me2 tags. Peaks were extended to 1 kb and restricted to those >3 kb 
from gene promoters.
Strain-Specific Feature and Motif Identification
To determine strain-specific binding and epigenetic modification events we counted the 
number of sequencing tags (normalized to 10 million) at peaks/regions identified in the set 
of combined peaks/regions from both strains. We normalized the mean peak tag count to be 
equal in each strain and compared the tag counts in each region and required strain-specific 
peaks/regions to exhibit ≥4-fold difference in tag counts and an adjusted cumulative Poisson 
p-value corresponding to FDR<1e-14 35 These criteria were based on empirical data relating 
replicate ChIP-seq experiments (Extended Data Fig. 1b). Individual genome sequences for 
C57BL/6J and BALB/cJ were constructed in regions of interest using the reference 
(C57BL/6J) sequence and replacing BALB/cJ alleles at SNPs and InDels reported in the vcf 
files from Keane et. al.17.
Strain-Specific Motifs
De novo motif finding in ChIP-Seq-enriched regions from both mouse strains was used to 
define position weight matrices (PWM) for transcription factors of interest (Extended Data 
Fig. 3a,b, Supplementary Table 1). These PWM were used to define strain-specific motifs 
by using the options homer2 –find <individual genome sequence> in HOMER for each 
genome sequence for the regions of interest. The positions of the identified motifs were 
compared between strains taking into account shifts cause by InDels relative to peak start 
coordinates and which DNA strand matched the identified motifs. Motifs with alignments 
only in one genome were considered strain specific.
PolyA RNA-Seq
For each condition, RNA was isolated from 5 × 106 thioglycolate-elicited macrophages with 
Trizol LS, and 15 μg RNA were DNase-treated using TURBO DNase (Ambion) according 
to the manufacturer's instructions and ethanol-precipitated. PolyA-RNA was selected from 7 
μg total RNA using the MicroPoly(A)Purist kit (Ambion), according to the manufacturer's 
instructions. The isolated RNA was hydrolyzed in 20 μl total volume with 2 μl RNA 
fragmentation buffer (Ambion) for 10 minutes at 70°C, the reaction stopped with stop 
buffer, and buffer was exchanged to Tris, pH 8.5 using P30 size exclusion columns (Bio-
Rad). The fragmented RNA (30 ng) was 5’-decapped in 21 μl total volume containing 0.5 μl 
tobacco acid pyrophosphatase (TAP, Epicentre), 2 μl 10× TAP buffer, 1 μl SUPERase-IN, 
incubate for 2 h at 37°C. To dephosphorylate RNA 3’ ends, 0.5 μl 10× TAP buffer, 1.5 μl 
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water, 0.5 μl 0.25 M MgCl2 (4.17 mM final –1 mM EDTA for maximum phosphatase 
activity), 0.5 μl 10 mM ATP (0.2 μM final to protect PNK) where added, and the reaction 
incubated with 1 μl PNK (Enzymatics) for 50 minutes at 37°C. RNA fragments were 5’-
phosphorylated by adding 10 μl 10× T4 DNA ligase buffer, 63 μl water, 2 μl PNK, and 60 
minute incubation at 37°C. RNA fragments were isolated using Trizol LS, precipitated in 
the presence of 300 mM NaAc and 2 μl Glycoblue (Ambion), washed twice with 80% 
ethanol and dissolved in 4.5 μl water.
To prepare sequencing libraries, 0.5 μl 9 μM of a 5’-adenylated sRNA3'MPX adapter /
5Phos/AG ATC GGA AGA GCA CAC GTC TGA /3AmMO/ (IDT, desalted; adenylated 
with Mth ligase (NEB) according to the manufacturer's instructions, phenol-chloroform/
chloroform-extracted, ethanol-precipitated with glycogen and dissolved in water at 9 μM) 
were heat-denatured together with the RNA for 2 minutes at 70°C, and ligated with 100 U 
truncated T4RNA ligase 2 K227Q (NEB) in 10 μl 1× T4 RNA ligase buffer without ATP, 
containing 10 U SUPERase-In and 15% PEG8000 for 2 hours at 16°C. To reduce adapter 
dimer formation, 0.5 μl 10 μM MPX_RT primer 5’-GTG ACT GGA GTT CAG ACG TGT 
GCT CTT CCG ATC T-3’ (IDT, desalted) was added and annealed to the ligation product 
by incubating at 75°C for 2 minutes, then 37°C for 30 minutes, then 25°C for 15 minutes. 
Finally, 0.5 μl 5 μM hybrid DNA/RNA sRNA5'h adapter 5’-GTT CAG AGT TCT ACA 
rGrUrC rCrGrA rCrGrA rUrC-3’ (IDT) were ligated to previously capped RNA 5’ ends by 
adding 2 μl T4 RNA ligase buffer, 6 μl 50% PEG8000 (15% final), 1 μl 10 mM ATP, 9.5 μl 
water and 0.5 μl (5 U) T4 RNA ligase 1 for 90 minutes at 20°C. To 15 μl ligation reaction, 
an additional 0.5 μl 10 μM MPX_RT primer were added, reactions were denatured at to 
70°C for 1 minute, then placed on ice. RNA was reverse-transcribed by adding 3 μl 10× first 
strand buffer, 4.5 μl water, 1.5 μl 10 mM dNTP, 3 μl 0.1 M DTT, 1.5 μl RNaseOUT and 1 μl 
Superscript III reverse transcriptase (Invitrogen), and incubating for 30 minutes at at 50°C. 
Complementary DNA was isolated by adding 35 μl AMPure XL beads (Beckman), binding 
and washing according to manufacturer's instructions and dissolved in 40 μl TET (0.1 % 
Tween 20/TE). Libraries were PCR-amplified for 9 (polyA RNA-Seq), 11 (5’-GRO-Seq), 
12 (rRNA--5'-RNA-Seq) or 13 (polyA-5’-RNA-Seq) cycles with 0.75 μM primers oNTI201 
and TruSeq-compatible indexed primers (e.g. 5’-CAA GCA GAA GAC GGC ATA CGA 
GAT nnn nnn GTG ACT GGA GTT CAG ACG TGT GCT CTT-3’ (desalted, IDT, index in 
lowercase letters) using Phusion Hot Start II (Thermo Scientific) in HF buffer containing 0.5 
M betaine (98°C, 30s/12x(98°C, 10s/57°C, 25s/72°C, 20s)/ 72°C, 1min/4°C, ∞), and 
175-225 bp fragments were size-selected on 10% PAGE gels. Libraries were diluted 1:105 
with TET and quantified relative to samples of known cluster density by SYBR green Q-
PCR with primers Solexa_1G_A 5’-AAT GAT ACG GCG ACC ACC GA-3’, 
Solexa_1G_B 5’-CAA GCA GAA GAC GGC ATA CGA-3’ (95°C, 15 min/25x(95°C, 10s/
60°C, 60 s)) and sequenced for 51 (insert) +7 (index) cycles on a HiSeq 2000 sequencer 
(Illumina) with small RNA sequencing primer 5’-CGA CAG GTT CAG AGT TCT ACA 
GTC CGA CGA TC-3’ and TruSeq Index sequencing primer (Illumina).
GRO-Seq
GRO-Seq was performed as described previously32 using 107 cells per condition. RNA at 
RefSeq transcripts was quantified for GRO-Seq and PolyA-RNA-Seq by counting the 
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normalized tags (to 10 million tags/experiment) in annotated exons for each RefSeq 
transcript.
Odds Ratio Calculations and Statistical Testing
Odds ratios for observing C57BL/6J-specific motif mutations relative to BALB/cJ-specific 
motif mutations in different classes of bound/modified loci (e.g., Fig. 2b) were calculated 
using (p1 / (1-p1)) / (p2 / (1-p2)) where p1 is the frequency of C57BL/6J-specific motifs and 
p2 is the frequency of BALB/cJ-specific motifs. For Extended Data Fig. 4j,k, p1 is the 
frequency of indicated events occurring in differentially bound loci and p2 is the frequency 
in similarly bound loci. Unless otherwise indicated, t-tests were two-sided assuming unequal 
variance.
eQTL Analysis
eQTL analysis was performed as previously described23,25. In brief, thioglycolate-elicited 
peritoneal macrophages were collected from 85 strains of mice. RNA was processed and 
hybridized to Affymetrix Genome HT_MG-430A. There were 22,416 probe sets analyzed 
after removing individual probes overlapping SNPs and probe sets with 8 or more probes 
overlapping SNPs. Expression data was RMA normalized.
3,918,755 SNPs with a minimum minor allele frequency of 10% originating from mouse 
Perlegen variation dataset36 were imputed across the strains37 and filtered to 3,695,041 
SNPs based on proximity (<2 Mb) to transcription start sites of transcripts detectable by the 
microarray. Gene expression for each transcript was associated to SNPs within 2 Mb using 
the efficient mixed-model association (EMMA) mapping that corrects for population 
structure38. Association p-values less than 1 × 10−5 (<1% FDR) were deemed significant23. 
The 3,695,041 SNPs used for association mapping were overlapped with H3K4me2 and 
H3K27Ac regions. Since H3K4me2 and H3K27Ac regions ranged from 500-1500 bp 
whereas haplotype blocks averaged 300 kb, we considered SNPs outside H3K4me2/
H3K27Ac regions that were in linkage disequilibrium (LD) with a SNP in H3K4me2/
H3K27Ac regions as overlapping. Haplotype Blocks were estimated in Haploview39 using 
143 strains with the following options: blockMAFThresh=0.1, blockCutLowCI=0.8, 
blockCutHighCI=0.98, blockRecHighCI=0.9, blockInformFrac=0.95. SNPs in LD with 
Enhancer SNP were considered markers of H3K4me2 regions. To test for enrichment of 
significant eQTL in H3K4me2 regions, we used the Hypergeometric Distribution Function 
as follows:
k successes = # significant eQTL in (or in LD with) H3K4me2 regions; m = # SNPs with 
significant eQTL, N = # total SNPs, n = # total SNPs in H3K4me2 regions.
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Macrophage eQTL enrichment in enhancers from other cell types
The short read archive files were downloaded from GEO Accession GSE2416420 for ChIP-
sequencing for the H3K27Ac mark in whole liver (SRX027340), pro-B cells (SRX027345), 
and ES cells (SRX027331, SRX027332) and input chromatin as background (liver: 
SRX027343, pro-B: SRX027348, ES: SRX027352). Sequencing reads were mapped to the 
C57BL/6J genome. H3K27Ac regions were identified where tag pileups exceeded 4X the 
input tags using HOMER6 and interrogated for enrichment of significant macrophage 
eQTLs as described for macrophage H3K4me2 and H3K27Ac regions above.
Reporter Assays and Mutation Analysis
One kb enhancers were PCR-amplified from C57BL/6J and BALB/cJ genomic DNA using 
genomic primers not overlapping variants that introduced terminal BamHI, BglII or BclI 
sites on one end and SalI or XhoI sites on the other end of the PCR products, depending on 
the restriction site content of the enhancer. These were digested with the respective 
restriction enzymes and ligated into a modified, BamHI and SalI-digested pGL4.10 
luciferase reporter plasmid (Invitrogen) containing a minimal HSV-TK promoter derived 
from pTAL-Luc (Clontech) (see Fig. 5a). Alternatively, 1 kb fragments were amplified 
using primers that introduced overhangs identical to the sequences flanking the BamHI/SalI 
tandem site in the pGL4.10 plasmid. Fragments were purified from the PCR reaction by 
SPRI using magnetic beads and cloned into the BamHI/SalI-cut reporter plasmid described 
above using Gibson Assembly master mix (NEB) according to the manufacturer's 
instructions. Mutations were introduced by PCR amplification with complementary primers 
containing the mutation to be introduced in the center, followed by DpnI digest of the 
template and transformation of bacteria. All constructs were confirmed by sequencing. For 
each reporter assay, 300 ng plasmid was transfected into RAW264.7 macrophages using 
SuperFect (Qiagen) together with 300 ng UB6 promoter-driven beta-galactosidase reporter 
for transfection normalization in 24-well plates seeded with 1 × 105 cells 24 hours prior to 
transfection. 24 hours post-transfection, media alone (RPMI + 10%FBS) or media also 
containing 100 ng/ml KLA was added for an additional 16 hours. Luciferase activity was 
measured 24 hr post transfection using a Veritas microplate luminometer (Turner 
Biosystems) and normalized to beta-galactosidase activity (Applied Biosystem) for 
transfection efficiency. Each experiment was performed at least three independent times, 
with each reaction done in triplicates. Data represented mean ± s.d., and statistical 
significance was determined by one-sided t-test.
Stable transfected cell lines were made by transient co-transfection of the linearized reporter 
plasmids together with linearized neomycin resistance-expressing pcDNA3 vector as 
described above, followed by incubation with 275 μg/ml Geneticin (G418 Sulfate, 
Invitrogen) for 2-3 weeks. Bulk cells from stably transfected colonies were tested for 
luciferase activity and normalized to total protein concentration (DC Protein Assay, 
BioRad).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Genetic variation affects LDTF binding
a, Model in which LDTFs (PU.1 and C/EBPα) establish regulatory function (explained in 
text) b, c, ChIP-Seq-defined binding intensity for PU.1 (b) and C/EBPα (c) in resting 
macrophages derived from C57BL/6J (x-axes) and BALB/cJ (y-axes). Dots represent 
normalized tag counts in 200 bp peaks. PU.1, C/EBPα and AP-1 motifs that were mutated in 
one genome (distinguished by symbol; C57BL/6J = red, BALB/cJ = blue) are highlighted 
for peaks with strain-specific binding (4-fold, FDR ≤ 1e-14). d, RNA-Seq-determined 
expression for genes nearest to strain-specific PU.1 or C/EBPα peaks. P-values are from 
one-tailed t-test. e, Variant frequency distributions for PU.1 binding ratio bins. Box midlines 
(d,e) are medians, boundaries are 1st/3rd quartiles, and whiskers extend to extremes. f, The 
percentage of polymorphic, strain-specific PU.1 and C/EBPα peaks with LDTF mutations. 
g, The observed position of SNPs generating strain-specific PU.1 motifs (n = 359) 
underlying differential (blue) or similar (red) PU.1 binding are shown. h. The proportion of 
NOD PU.1 motif mutations that abolished PU.1 binding for each group is shown (details in 
Extended Data Fig. 5).
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Figure 2. Genetic variation supports the LDTF collaborative binding model
a, Normalized ChIP-Seq signal at 342 loci defined by strain-specific PU.1 and/or C/EBPα 
binding and containing LDTF motif mutations (rows) plotted for each factor/modification 
(columns). Left columns display SNPs as grey dots with mutated motifs highlighted by color 
(LDTF mutation labels at left). b, Log2 odds ratios for observing strain-specific motif 
mutations at strain-specific (>2-fold tag ratio, left and right bins) and similar (<2-fold tag 
ratio, middle bin) PU.1 peaks (details in Methods). c, Gene expression for genes nearest 
promoter-distal (>3 kb), strain-specific H3K4me2 and H3K27Ac peaks are shown 
(described in Fig. 1d). d, Normalized H3K27Ac log2 tag ratios (1 kb, y-axis) versus 
log2(PU.1xC/EBPα) tag strain ratios (200 bp, x-axis) for loci with PU.1 or C/EBPα binding. 
Strain-specific motif mutations are indicated by symbol and color. The distribution of 
H3K27Ac strain ratios stratified by strain mutations are shown (2-sided t-test). e, 
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Enrichment significance (hypergeometric distribution testing, see Methods) of H3K27Ac-
modification in eQTLs from different cell types are shown.
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Figure 3. Validation of predicted binding and modification patterns
a, PU.1 binding at strain-specific loci are shown for C57BL/6J, BALB/cJ, and NOD/ShiLtJ 
mouse macrophages (columns; red = binding, white = no binding). All loci contain a strain-
specific PU.1, C/EBP, or AP-1 motif. The NOD haplotype at these loci is indicated by the 
sidebar (red = BALB/cJ, blue = C57BL/6J, yellow = mixture). b, PU.1 binding, SNPs 
(lines), allele sharing, motif alignment and genome sequence are shown for a locus where 
NOD broke the C57/BALB haplotypes. c,d, Allele-specific ChIP-Seq ratios (y-axes) for PU.
1 (c) and H3K27Ac (d) in CB6F1/J hybrid macrophages versus ChIP-Seq reads in parental 
strains (BALBc/C57 log2 ratios; x-axes) are shown for strain-specific peaks (blue = 
C57BL/6J, red = BALB/cJ-specific) and similarly-bound peaks (black) as defined by 
parental data.
Heinz et al. Page 18
Nature. Author manuscript; available in PMC 2014 May 28.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Figure 4. RelA/p65 binding is largely determined by LDTF binding
a, Strain-specific p65-bound regions were segregated into rows according to the bound 
strain (colored side bar). Binding/modification is shown with and without 100 ng/ml KLA 
treatment (−/+, 3rd header row). As in Fig. 2a, SNPs are indicated by grey dots and mutated 
motifs are highlighted by color (labeled beneath). b, The log2 odds ratio for observing 
strain-specific mutations are shown for bins of p65 binding as described in Fig. 2b. c, The 
percentage of polymorphic, differentially bound p65 loci harboring LDTF or NF-κB motif 
mutations is shown. d, The ratio of variant counts in strain-specific versus strain-similar 
peaks (y-axis) are shown relative to the peak centers for PU.1-, C/EBPα-, and p65-bound 
peaks in 10 bp bins (x-axis), smoothed using cubic spline. e, The relative amount of 
transcription (GRO-Seq) and mRNA production between strains after KLA treatment at the 
nearest gene to strain-specific p65 loci is shown. P-values are from one-tailed t-test.
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Figure 5. Validation of strain-specific enhancer activity and causal variants
a, Enhancer reporter schematic. One kb enhancer-like fragments were cloned downstream of 
an HSV-TK-luciferase reporter gene and tested for basal and KLA-inducible transcriptional 
activity in RAW264.7 macrophages. b, Genomic features (left) and regulatory activities 
(right) of the strain-similar PU.1 -14 kb enhancer positive control from C57BL/6J and 
BALB/cJ-derived macrophages. (Extended Data Fig. 9-10 show all 33 loci tested). In the 
left panel the horizontal midline represents the 1 kb stretch of cloned DNA and SNPs are 
indicated with vertical black lines. ChIP-Seq tag pile-ups are shown for PU.1 (green), C/
EBPα (blue), p65 (red), H3K27Ac (purple), and H3K4me2 (orange) for C57BL/6J (above 
midline) and BALB/cJ (below midline) with identical scales after KLA treatment (100 
ng/ml, 1 h). c, Representative example of a strain-specific locus and the effect of a single 
base pair swap at the indicated PU.1 motif SNP on enhancer activity. See Extended Data 
Fig. 10b,c for additional examples and allele-swapping controls. Bargraphs plot mean ± s.d.
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Extended Data Figure 1. ChIP-Seq data characteristics
a, Summary of ChIP-Seq features identified. The number of ChIP-seq regions/peaks 
identified in untreated primary thioglycolate-elicited macrophages are tabulated for 
H3K4me2, H3K27Ac, PU.1 and C/EBPα. Peaks for p65 were quantified in macrophages 
treated with 100 ng/ml KLA for 1 hr. Unless otherwise noted, modification and binding 
were considered strain-specific at ≥4-fold difference between strains in sequenced tags and 
the FDR was <1e-14 based on Poisson cumulative distribution testing and Benjamini & 
Hochberg correction. b-e, Reproducibility and strain-specific binding. Two separate pools of 
thioglycolate-elicited macrophages from mice from each strain (C57BL/6J, BALB/cJ) were 
treated with KLA for 1 hour. ChIP-seq for p65 was performed separately on each pool (see 
Methods). The number of normalized sequencing tags at the union of peaks identified in the 
indicated experiments is shown. Peaks highlighted in red were deemed experiment-specific 
using criteria applied throughout this study (4-fold, and FDR<1e-14 from the cumulative 
Poisson distribution and Benjamini and Hochberg FDR estimation). The number of 
experiment-specific peaks is indicated (red) relative to the total number of peaks (black). f, 
Comparison of the p65 log2 peak tag ratio between strains and experimental sets for all 
peaks (black), highlighting experiment-specific peaks (red) identified in either (d) or (e). g, 
Heat map showing pairwise correlation between all p65 experiments. Pearson correlation 
coefficients are given for each comparison.
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Extended Data Figure 2. Strain-specific LDTF binding correlates with variant density and 
location in LDTF motifs but not with genomic context
a, Genomic features do not distinguish between strain-similar and strain-specific LDTF 
binding. Peaks were restricted to promoter-distal peaks (> 3 kb to gene start sites). Genomic 
features (distance to nearest gene, distance to nearest repeat, CpG content, conservation 
score) were compared among three pairs of strain-similarly bound and strain-specifically 
bound PU.1 and/or C/EBPα loci (listed as Group 1 – Group 6). Box midlines are medians 
and boundaries are 1st and 3rd quartiles. Whiskers extend to the extreme data points. CpG 
content and conservation were quantified in 1 kb regions centered on the LDTF peak. P-
values from 2-sided t-test are given if below 0.05. b, Strain-specific C/EBPα binding occurs 
in regions with increased variant density. ChIP-Seq tag counts in 200 bp peak regions were 
stratified into 5 bins according to log2 ratios of peak tag counts in BALB/cJ versus 
C57BL/6J (x-axis, log2 ratio) and the variant density distributions are shown per bin. c,d, 
Variant density distribution in strain-specific peaks. Mean variant densities within 10 bp 
bins relative to ChIP-Seq peak centers in strain-similar (red) or strain-specific peaks (blue). 
e, Strain-specific PU.1 binding correlates with mutations in their respective motifs. PU.1 
motif mutations were quantified in PU.1-bound regions and plotted against the logarithmic 
ratio of PU.1 peak tag counts in each strain (binding ratio) (x-axis). The frequency of motifs 
that were mutated in BALB/cJ are plotted in red and those mutated in C57BL/6J in blue. f, 
The analogous relationship as shown in e for PU.1 is plotted for C/EBP motif mutations 
versus C/EBPα strain binding ratio.
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Extended Data Figure 3. Strain-specific PU.1 and C/EBPα binding correlates with strain-specific 
LDTF motifs
a, Top and degenerate motifs enriched in H3K4me2 and PU.1 or C/EBPα ChIP-Seq peaks. 
b, NF-κB consensus and degenerate motifs enriched in p65 ChIP-Seq peaks. These motifs 
were used to query individual genome sequences and identify strain-specific motifs in 
subsequent analysis. Degenerate/’weak’ motif occurrence numbers for a given factor include 
ChIP-Seq peaks containing ‘strong’ motifs. Position weight matrices and log-odds score 
thresholds for each motif are given in Supplementary Table 1. c, Mutations in LDTF motifs 
affect PU.1 and d, C/EBPα binding. The left panels show scatterplots for the ChIP-Seq-
defined binding of PU.1 (c) and C/EBPα (d) between C57BL/6J (x-axes) and BALB/c (y-
axes). Strain-specific motifs were queried within 100 bp of each peak position. Red symbols 
designate binding events at loci where a polymorphism mutated a C/EBP, PU.1, or AP-1 
motif in the C57BL/6J genome, whereas the motif was intact in the BALB/cJ genome. Blue 
points highlight mutations in these motifs in the BALB/cJ genome only. Violin plots in the 
right panels show the effect of each motif mutation (along x-axes: PU.1, C/EBP, AP-1 and 
NF-κB) on the ratio of PU.1 (c) and C/EBPα (d) binding between mouse strains, (y-axes: 
positive values = BALB/cJ-specific, negative values = C57BL/6J-specific). Tag ratio 
distributions for peaks overlapping C57BL/6J motif mutations are on the left (light colors), 
those for peaks overlapping BALB/cJ motif mutations are on the right (dark colors). The 
fold-difference between mean binding ratios is indicated under the pair of distributions for 
each motif. The grey distribution indicates PU.1- or C/EBPα- bound loci not overlapping 
strain-specific motifs.
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Extended Data Figure 4. Effects of cognate motif distance from peak center, variant position 
within a motif and the presence of alternative motifs on strain-differential binding of PU.1 and 
C/EBPα
a-d, PU.1 and C/EBP motif mutations near the experimentally derived peak center are 
associated with impaired binding. a,c, The ratios of the frequencies of variant-containing 
motifs at the given distances from strain-differentially vs. strain-similarly bound peak 
centers (>2-fold vs. <2-fold tag count ratio) for 570 PU.1 (a) and 278 C/EBP (b) variant-
containing motifs are shown, respectively. b,d, The distribution of absolute strain peak tag 
count ratios of peaks whose center is at the given distances from mutated PU.1 (b) or C/EBP 
(d) motifs. Box midlines are medians and boundaries are 1st and 3rd quartiles. Whiskers 
extend to the extreme data points. P-values are from 2-sided t-test. e,f, Effects of alternative 
PU.1 and C/EBP motifs and core mutations on binding. The number of non-mutated, 
“alternate”, PU.1 or C/EBP motifs in the strain with a PU.1 or C/EBP motif mutation were 
counted and the absolute respective PU.1 or C/EBPα log2 strain binding ratio is shown. g, 
Defining the C/EBP motif core by comparing differential vs. similar C/EBPα binding. 
Sequence variants within C/EBP motifs located in loci devoid of alternate C/EBP motifs (n 
= 178) were counted according to whether they were in differential (blue) or similar (red) C/
EBPα-bound peaks. h, The distribution of PU.1 binding strain log2 ratios (x-axis) is shown 
for PU.1 mutations located in the PU.1 core and non-core nucleotides (defined in Fig. 1g). i, 
The C/EBPα binding strain log2 ratio is shown for C/EBP core and non-core mutations as 
defined in g. j,k, Motif mutations predominately occur at differentially bound loci. The odds 
ratios (x-axis; equation shown in box) describing the relative effect of the indicated 
characteristics of mutated motifs on differential binding relative to similar binding are 
shown for PU.1 (j) and C/EBPα (k). Whiskers show 95% confidence intervals. l,m, The 
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percentage of respective motif mutations consistent with altered PU.1 (l) and C/EBPα (m) 
binding are shown for the indicated categories of motif mutations.
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Extended Data Figure 5. Analysis pipeline for predicting functional PU.1 mutations in NOD
Data is shown in Fig. 1h.
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Extended Data Figure 6. LDTF motif mutations are enriched at strain-specific C/EBPα-bound 
loci relative to strain-similar loci
a, The log2 odds ratio for observing a C57BL/6J- versus BALB/cJ-specific mutation in the 
indicated for three bins of C/EBPα binding ratios: similar (middle bin), or strain-specifically 
C/EBPα bound (left and right bins). Details in the Methods section. b, Collaborative binding 
is largely not mediated by direct protein-protein interactions. 14,199 loci bound by PU.1 and 
C/EBPα were centered on the PU.1 weak motif (0 on x-axes) and cumulative instances of 
C/EBP and AP-1 motifs were plotted at each position relative to the central PU.1 motif. 
Interferon response factor (IRF) half-sites are plotted as control for a factor that requires 
direct protein-protein interactions with PU.1 for DNA binding. The motifs in each 
comparison showing overlapping sequence and base pair distances are indicated to the right. 
Peak distances from the central PU.1 motif are indicated in the histograms. ‘rc’ in b stands 
for reverse complement. c, Allelle-specific C/EBPα binding in F1 heterozygotes is similar to 
binding in homozygous parental strains. C/EBPα ChIP-seq reads from CB6F1/J Hybrid F1 
macrophages were mapped with no mismatches to both parental genome sequences to 
identify allele-specific reads. C/EBPα log2 peak tag ratios between the parental strains 
(BALB/cJ vs. C57BL/6J) are shown on the x-axis and the log2 ratio of allele-specific reads 
in the F1 Hybrids are shown on the y-axis (BALB/cJ allele vs. C57BL/6J allele). C57BL/6J-
specific C/EBPα regions are blue, BALB/cJ-specific C/EBPα regions are red, and strain-
similar C/EBPα regions are black. Strain-specific or similar regions were defined from 
parental data.
Heinz et al. Page 27
Nature. Author manuscript; available in PMC 2014 May 28.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Extended Data Figure 7. Strain-specific epigenetic marks correlate with LDTF binding, and 
LDTF mutations segregate with altered H3K4me2 deposition
a-f, Strain-specificity of LDTF binding and epigenetic marks. The relative amount of 
H3K4me2 (a-c) and H3K27Ac (d-f) between C57BL/6J and BALB/cJ (x-axes) is highly 
correlated with the amount of PU.1, C/EBPα, or the product (PU.1*C/EBPα) bound. The 
log2 ratios of the peak tag counts for PU.1, C/EBPα and PU.1*C/EBPα in each strain is 
shown relative to the log2 of the peak tag count ratios for H3K4me2 or H3K27Ac, 
respectively. Loci containing strain-specific LDTF motifs in a differentially PU.1 or C/
EBPα bound peak are highlighted. Correlation coefficients (Pearson) are indicated for each 
comparison. g, LDTF mutations segregate with altered H3K4me2 deposition. The log2 of 
the ratio of the product of the normalized peak tag counts for PU.1 and C/EBPα in 200 bp in 
each strain (x-axis) is compared to the log2 H3K4me2 peak tag ratio in 1 kb (y-axis) for loci 
containing at least a PU.1 or C/EBPα peak. Strain-specific LDTF motif mutations are 
indicated by the designated symbols and colored by the mutated strain (C57BL/6J red, 
BALB/cJ blue). The distribution of H3K4me2 strain ratios stratified by corresponding 
LDTF strain mutations are shown to the right with p-value from a 2-sided t-test. h, 
Relationships between H3K27Ac patterns in different cell types. Hierarchical clustering of 
H3K27Ac-positive regions as determined by ChIP-Seq and analysis with HOMER. The 
number of ChIP-seq tags in each of the 86,264 H3K27Ac-marked regions used for 
comparison with eQTL data in Fig. 2e that were detected in at least one cell type were 
clustered using Euclidean distance.
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Extended Data Figure 8. LDTFs prime the p65 cistrome
a, The 69,517 regions that gained p65 in C57BL/6J upon KLA treatment were analyzed for 
binding of PU.1 and C/EBPα without and with KLA treatment as shown in the pie charts. 
Loci not bound by PU.1 or C/EBPα after KLA treatment were analyzed by de novo motif 
finding. The most enriched motif was AP-1 and the second-most enriched motif was NF-κB. 
b, Violin plots of the p65 strain ratios of mean-normalized p65 binding for p65-bound peaks 
stratified by motifs mutations present in either BALB/cJ or C57BL/6J. Mutated motifs 
included PU.1 (strong and weak), C/EBP (strong and weak), C/EBP:AP-1, AP-1, and NF-
κB. The effect on p65 binding per group is shown by comparing the mean-normalized p65 
tag binding ratio along the y-axis (log2(BALB/cJ / C57BL/6J), positive values = BALB/cJ-
specific, negative values = C57BL/6J-specific). White circles indicate the distribution 
means, and the average fold change associated with C57BL/6J-mutating and BALB/cJ-
mutating SNPs in the respective motifs is given beneath. One-sided t-test p-values between 
each pair of distributions ranged from 1e-29 to 1e-14. c, Variant density in strain-specific 
and strain-similar p65 peaks. Mean variant density within 10 bp bins relative to p65 ChIP-
Seq peak centers in strain-similar (red) or strain-specific peaks (blue). d-e, The variant 
density distribution in strain-specific p65 peaks is broader than those for PU.1 or C/EBPα. 
Fold enrichment of variant densities in strain-specific relative to strain-similar peaks (y-
axes) for PU.1 (d), C/EBPα (e) and p65 (f) are shown relative to the peak centers (x-axes). 
Ratios plotted in d and e are from data in Extended Data Fig. 2c,d, respectively.
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Extended Data Figure 9. Validation of strain-specific enhancer activity
a, Enhancer activity in transient reporter assays correlates with strain-specific LDTF and 
p65 binding. Luciferase assay results for 24 loci (20 strain-specific enhancers with strain-
specific motifs, 1 positive control with strain-similar enhancer activity (row 7, column 3), 2 
negative controls lacking enhancer activity in both strains (row 8, columns 1 and 2), and 1 
strain-specific enhancer lacking a strain-specific motif (row 8, column 3) in transiently 
transfected RAW 264.7 cells 48 hours after transfection. Each 1 kb locus is represented by 
the horizontal midline within a box (see Fig. 5). ChIP-seq tag pileups are shown for PU.1 
(green), C/EBPα (blue), p65 (red), H3K27Ac (purple), and H3K4me2 (orange) for 
C57BL/6J (above midline) and BALB/cJ (below midline) with identical scales. Binding/
modification data are shown after treatment with 100 ng/ml KLA. Vertical black lines 
indicate SNP locations. Horizontal bars indicate average luciferase (enhancer) activity of the 
empty vector (blue, no enhancer), activity of a locus cloned from either strain in grey 
C57BL/6J (above) and BALB/cJ (below) under basal conditions, or after overnight 
stimulation with 100 ng/ml KLA (pink). Luciferase values from transiently transfected cells 
were normalized to the activity measured for a co-transfected UB6 promoter-β-Gal reporter 
construct. Empty vector values were scaled to 0.5 for the first four loci and to 1 for the 
remaining loci. Error bars show standard deviations calculated from 3 biological replicates, 
average values are indicated next to each bar. Experiments were replicated at least 3 times. 
Significant strain-specific enhancer activity is indicated by § (grey without treatment, red 
after KLA treatment, one-tailed t-test, p-value < 0.05). b, Chromatinization is necessary for 
the strain specificity of a subset of enhancers. RAW264.7 cells were stably transfected with 
the two constructs harboring the loci that showed strain-specific binding but lacked strain-
specific enhancer activity in transient reporter assays (row 4, column 1 and row 1, column 3, 
marked by *). Luciferase activity measured in lysates of stably transfected cells was 
normalized to total protein content.
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Extended Data Figure 10. Motif analysis identifies causal SNPs in enhancers
Regions of ~1 kb size centered on PU.1 or C/EBPα ChIP-Seq peaks of similar tag count in 
C57BL/6J and BALB/cJ (< 2-fold difference) that contain a variant in a motif for the 
respective factor within 100 bp of the peak center were cloned into a luciferase reporter 
plasmid containing a minimal HSV-TK derived promoter. Three independent transient 
transfection experiments were performed in RAW264.7 cells, with triplicate transfections of 
each construct. Where indicated, variant nucleotides in a motif were mutated to that present 
in the other strain, and the resulting enhancer activity was scored relative to the wild-type 
allele. Shown are the ratios of the normalized luciferase activity of the C57BL/6J vs 
BALB/cJ alleles from a representative experiment. Luciferase values from transiently 
transfected cells were normalized to the activity measured for a cotransfected UB6 promoter 
β-Gal reporter construct, error bars represent derived standard deviations calculated by 
Gaussian error propagation. Constructs exhibiting significantly different activity ratios in 
two out of three experiments as determined by two-sided t-test (p < 0.05) are marked with a 
star. Strain and motif mutated by a variant are indicated below. In the table below, plus signs 
indicate whether a tested enhancer contains an alternative motif for the same factor, a variant 
at a motif position that is not located at a motif core as defined in Fig. 1g and Extended Data 
Fig. 4g, or a variant in a motif located less than 20 bp away from the peak center. 
Characteristics of the loci and primer sequences are in Supplementary Table 3. b, 
Identifying causal variants by motif analysis. Left panels show the ChIP-Seq pileups and 
SNP locations as in Extended Data Fig 9. Right panels plot the relative enhancer reporter 
luciferase activities of the loci shown on the left, either in the wild type configuration or 
when swapping the SNP indicated by a black triangle by site-directed mutagenesis. Motifs 
mutated by the indicated SNPs are shown above, with the mutation underlined and in red. c, 
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To confirm that the centrally located PU.1 motif is essential for the C57BL/6J- specific 
activity, a 1 kb fragment of the locus from C57BL/6J or BALB/cJ was cloned into the 
luciferase reporter described in Fig. 5 and the effects of swapping alleles at the predicted 
causal PU.1 SNP and flanking control 5’ and 3’ SNPs on enhancer activity are shown. 
Swapping alleles at the PU.1 SNP reversed strain-specific enhancer activity whereas 
swapping alleles at either flanking SNP had no significant effect.
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